Page last updated: 2024-10-21

3-methylcholanthrene and Hyperinsulinism

3-methylcholanthrene has been researched along with Hyperinsulinism in 1 studies

Methylcholanthrene: A carcinogen that is often used in experimental cancer studies.
3-methylcholanthrene : A pentacyclic ortho- and peri-fused polycyclic arene consisting of a dihydrocyclopenta[ij]tetraphene ring system with a methyl substituent at the 3-position.

Hyperinsulinism: A syndrome with excessively high INSULIN levels in the BLOOD. It may cause HYPOGLYCEMIA. Etiology of hyperinsulinism varies, including hypersecretion of a beta cell tumor (INSULINOMA); autoantibodies against insulin (INSULIN ANTIBODIES); defective insulin receptor (INSULIN RESISTANCE); or overuse of exogenous insulin or HYPOGLYCEMIC AGENTS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
GLORGIO, I1
BONOMO, GM1
VAILATI, G1

Other Studies

1 other study available for 3-methylcholanthrene and Hyperinsulinism

ArticleYear
[The influence of a condition of hyperinsulinism on the production of experimental tumors with 3-methylcholanthrene].
    Bollettino della Societa italiana di biologia sperimentale, 1961, Dec-31, Volume: 37

    Topics: Animals; Hyperinsulinism; Leadership; Methylcholanthrene; Neoplasms; Neoplasms, Experimental

1961